DeepRad.AI

What DeepRad.AI does

DeepRad.AI is a Taiwan-based medical imaging AI company founded in 2023 and headquartered in Nangang District, Taipei City, with 11-50 employees. The company develops AI-powered diagnostic support systems for radiology, focused on early detection of medical conditions including lung cancer, coronary artery calcifications, dementia, and brain concussions. Its commercial portfolio includes two products: DeepLung-CAC, which analyzes low-dose CT images to identify lung nodules, coronary artery calcifications, and bone density abnormalities in a single examination, and DeepBrain-Cognito, which uses 4D brain cortical thinning pattern analysis to predict dementia via standard clinical dementia rating (CDR) scores. Two additional products, DeepBreast (breast cancer screening) and DeepBrain-Concussion (postconcussion syndrome decision support), are in the development pipeline.

The technology stack combines computer vision applied to medical imaging data with predictive analytics, leveraging the NVIDIA Inception Program, ADLINK Edge AI platforms (DLAP series), and Phison's aiDAPTIV+ acceleration — demonstrated publicly at NVIDIA GTC 2026. Models are trained in collaboration with top-tier radiologists and validated through clinical partnerships with Taiwan-based hospitals including Landseed International Medical Group (聯新國際醫療集團), Wanfang Hospital (萬芳醫院), and Fu Jen Catholic University Hospital (輔仁大學附設醫院), as well as academic institutions including National Yang Ming Chiao Tung University (國立陽明交通大學) and UC Berkeley School of Public Health.

The business model is enterprise software licensing for healthcare providers — primarily hospitals, health centers, and radiologists — with an implied subscription or recurring revenue structure. Pricing is contact-based and not publicly disclosed. Go-to-market combines direct enterprise sales, embedded distribution through ADLINK's Edge AI platforms, and visibility-driven event marketing at NVIDIA GTC, InnoVEX, and SelectUSA. Primary customer segments are radiologists and hospitals/health centers, with patients (indirect beneficiaries) and insurance providers (prospective) as secondary segments. The stated value proposition centers on accelerating screening workflows, enabling opportunistic screening to increase hospital revenue, and improving diagnostic accuracy through AI-assisted reporting.

Name

DeepRad.AI

Legal name

DeepRad.AI Inc.

Website

https://deepradai.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

DeepRad.AI is a Taiwan-based medical imaging AI company (11-50 employees) developing AI diagnostic support systems — DeepLung-CAC and DeepBrain-Cognito — for early detection of lung, cardiac, and cognitive conditions, serving hospitals, health centers, and radiologists through enterprise software licensing.

Ownership category

akta.pro rank

Product category

AI Medical Imaging Software

NAICS

Software Publishers (513210), Diagnostic Imaging Centers (621512)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHABAJ

Radiology AI, CAD & Advanced Visualization Software

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

SECONDARYHLACANAG

SaMD – Imaging & Signal Analysis (AI/ML)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHDAAAEAH

Medical Imaging AI

Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Computer Vision & Video Analytics

SECONDARYHLACALAG

AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)

Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

• AI medical imaging
• Radiology diagnostics
• Lung cancer screening
• Dementia detection
• Preventive healthcare

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. AI Medical Imaging Software: DeepRad.AI offers AI-powered diagnostic support systems (DeepLung-CAC, DeepBrain-Cognito) to healthcare providers including hospitals, health centers, and radiologists. The revenue model appears to be enterprise software licensing with AI serving as a medical assistant to increase productivity and reduce errors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

DeepRad.AI develops AI-powered medical imaging software that assists radiologists and healthcare providers in the early detection of medical conditions. Its core products include DeepLung-CAC, which screens lungs, heart, and spine from low-dose CT images to identify lung nodules, coronary artery calcifications, and bone density abnormalities, and DeepBrain-Cognito, which analyzes 4D brain cortical thinning patterns to support early dementia detection. The company is positioned as an AI medical assistant that increases radiologist productivity, reduces diagnostic errors, and enables opportunistic screening for hospitals.

Product overview

DeepRad.AI is an AI-powered medical imaging screening platform focused on early detection and preventive medicine. The company's portfolio includes two core products: DeepLung-CAC for AI-powered lung, heart, and spine screening via CT imaging, and DeepBrain-Cognito for cognitive screening and dementia detection via brain cortical analysis. Two additional screening products are in development: DeepBreast for breast cancer screening and DeepBrain-Concussion for concussion syndrome assessment. All products leverage computer vision AI and predictive analytics to assist radiologists, hospitals, and healthcare providers in accelerating screening workflows and improving diagnostic accuracy.

Differentiator

Problem solved

Functional benefit

Brands

• DeepLung-CAC: AI-powered Lung Cancer Screening Platform - an all-in-one AI diagnostic support system that can screen lungs, heart, and spine in a single exam, identifying lung nodules, coronary artery calcifications, and bone density abnormalities.
• DeepBrain-Cognito
• DeepBreast
• DeepBrain-Concussion

Products and services

• DeepLung-CAC AI-powered all-in-one diagnostic support system that screens lungs, heart, and spine in a single low-dose CT exam, identifying lung nodules, coronary artery calcifications, and bone density abnormalities for early detection in middle-aged and older populations. Sold to hospitals, health centers, and radiologists as a screening and decision-support tool.
• DeepBrain-Cognito AI-powered cognitive screening platform that portrays patterns of regional brain cortical thinning in 4D and produces standard clinical dementia rating (CDR) scores to facilitate early detection of dementia and advance preventive medicine. Sold to hospitals, health centers, and radiologists as a dementia screening and decision-support tool.

Quantifiable outcome

• DeepLung can screen lungs, heart, and spine in a single exam
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• ADLINK TechnologycoreTechnology or Integration · 12 March 2026ADLINK Technology showcased DeepRad.AI's medical imaging solutions integrated with Phison's aiDAPTIV+ technology at NVIDIA GTC 2026. DeepRad.AI's solutions are part of ADLINK's Edge AI platforms demonstration for AI-powered medical imaging applications, highlighting integration into DLAP series platforms.
• Phison Electronics (aiDAPTIV+)coreTechnology or Integration · 12 March 2026DeepRad.AI's medical imaging solutions are integrated with Phison's aiDAPTIV+ technology, enabling high-performance edge AI acceleration for medical imaging applications.
• NVIDIA Inception ProgramcoreTechnology or IntegrationDeepRad.AI is a member of NVIDIA's Inception Program, which supports cutting-edge startups working on GPU-accelerated AI applications. This partnership provides access to NVIDIA technology, resources, and ecosystem support.
• 聯新國際醫療集團 (Landseed International Medical Group)coreStrategic or Co-development PartnerPartnership with Landseed International Medical Group for AI-powered medical imaging solutions deployment in healthcare settings.
• 國立陽明交通大學 (National Yang Ming Chiao Tung University)coreStrategic or Co-development PartnerAcademic partnership with National Yang Ming Chiao Tung University for AI healthcare research and development collaboration.
• 萬芳醫院 (Wanfang Hospital)coreStrategic or Co-development PartnerPartnership with Wanfang Hospital for AI-powered medical imaging solutions deployment and clinical validation.
• 輔仁大學附設醫院 / FATA高齡加速器 (Fu Jen Catholic University Hospital / FATA Aging Accelerator)coreStrategic or Co-development PartnerPartnership with Fu Jen Catholic University Hospital and FATA Aging Accelerator for AI-powered medical imaging solutions in geriatric care settings.
• UC Berkeley School of Public HealthminorStrategic or Co-development PartnerInternational academic partnership with UC Berkeley School of Public Health for research collaboration in public health and AI applications.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Lunit: Korean publicly-listed radiology AI company best known for Lunit INSIGHT CXR (chest X-ray) and INSIGHT MMG (mammography). Closely comparable to DeepRad.AI given overlapping focus on AI-driven cancer screening and an Asia-Pacific commercial base.
• Qure.ai: Mumbai-based radiology AI company with FDA-cleared products for chest CT, head CT, and chest X-ray triage. Directly comparable to DeepRad.AI's DeepLung-CAC and DeepBrain lines on AI-driven detection of lung and brain abnormalities.
• Aidoc: Israeli/US radiology AI platform offering a broad suite of FDA-cleared triage and detection algorithms deployed across hundreds of US hospitals. Directly comparable as a multi-condition AI imaging vendor targeting enterprise hospital systems.
• RapidAI: US-based imaging AI company specializing in stroke and vascular imaging workflow (Rapid CT Perfusion, Rapid MRI). Comparable to DeepRad.AI as an enterprise radiology AI workflow vendor selling into hospital networks, with a more vascular focus.
• Infervision: Chinese radiology AI company with CT lung nodule, chest X-ray, and stroke detection products deployed across China and parts of Asia. Comparable to DeepRad.AI on lung CT screening and Asia-centric go-to-market, though with a larger China footprint.
• Annalise.ai: Australia-based radiology AI company offering a comprehensive 141-finding chest X-ray and CT head model. Comparable to DeepRad.AI as a multi-finding AI imaging vendor with APAC roots pursuing global hospital expansion.
• Viz.ai: US-based enterprise imaging AI platform best known for LVO stroke triage with deep EHR integration. Comparable to DeepRad.AI as a hospital-deployed AI imaging workflow vendor, with a narrower neurovascular focus.
• Nanox AI (formerly Zebra Medical Vision): Israel-based radiology AI vendor (now under Nanox) offering population-health imaging analytics across multiple body parts. Comparable to DeepRad.AI on multi-condition opportunistic screening and risk-stratified reporting.

Broad incumbents

• DeepHealth (a RadNet company): US-based radiology AI subsidiary of RadNet with FDA-cleared products (Saige-Dx for breast, prostate, thyroid). Comparable to DeepRad.AI on AI-assisted cancer screening at scale, with much deeper US deployment via RadNet's imaging center network.
• Philips (IntelliSpace AI): Global medical imaging OEM with an embedded AI marketplace (IntelliSpace AI) hosting third-party and proprietary radiology algorithms. Comparable to DeepRad.AI as a channel and competitive incumbent whose installed base of PACS/Imaging systems shapes hospital AI procurement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php?id=100094731975496
• LinkedInlinkedin.com/company/deeprad-ai

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DeepRad.AI